Ending childhood obesity: a time for action
S Nishtar, P Gluckman, T Armstrong - The Lancet, 2016 - thelancet.com
S Nishtar, P Gluckman, T Armstrong
The Lancet, 2016•thelancet.com1 Kaiser T, Feng G. Modeling psychiatric disorders for developing effective treatments. Nat
Med 2015; 21: 979–88. 2 Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia
using human induced pluripotent stem cells. Nature 2011; 473: 221–25. 3 Mariani J,
Coppola G, Zhang P, et al. FOXG1-dependent dysregulation of GABA/glutamate neuron
differentiation in autism spectrum disorders. Cell 2015; 162: 375–90. 4 Chen HM, DeLong
CJ, Bame M, et al. Transcripts involved in calcium signaling and telencephalic neuronal fate …
Med 2015; 21: 979–88. 2 Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia
using human induced pluripotent stem cells. Nature 2011; 473: 221–25. 3 Mariani J,
Coppola G, Zhang P, et al. FOXG1-dependent dysregulation of GABA/glutamate neuron
differentiation in autism spectrum disorders. Cell 2015; 162: 375–90. 4 Chen HM, DeLong
CJ, Bame M, et al. Transcripts involved in calcium signaling and telencephalic neuronal fate …
1 Kaiser T, Feng G. Modeling psychiatric disorders for developing effective treatments. Nat Med 2015; 21: 979–88. 2 Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221–25. 3 Mariani J, Coppola G, Zhang P, et al. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell 2015; 162: 375–90.
4 Chen HM, DeLong CJ, Bame M, et al. Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients. Transl Psychiatry 2014; 4: e375. 5 Madison JM, Zhou F, Nigam A, et al. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities. Mol Psychiatry 2015; 20: 703–17.
thelancet.com